Skip to content

The relationship between Pan-vascular diseases and postoperative delirium in elderly patients undergoing joint replacement: a prospective cohort study

The relationship between Pan-vascular diseases and postoperative delirium in elderly patients undergoing joint replacement: a prospective cohort study - The relationship between Pan-vascular diseases and postoperative delirium in elderly patients undergoing joint replacement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102428
Enrollment
Unknown
Registered
2025-05-14
Start date
2024-10-12
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

patients with pan-vascular diease:none
patients with non-pan-vascular diease:none

Sponsors

First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: ASA II to III level, 60 to 80 years old, patients undergoing first joint replacement surgery sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with preoperative communication difficulties (such as coma, severe dementia, speech disorders, or severe visual or auditory impairments); those with significantly reduced preoperative SDMT, trail-making test, and auditory verbal learning test results; patients with severe heart, liver, or kidney diseases; a history of neurological or psychiatric disorders; those taking psychiatric medications; patients who have previously undergone intracranial surgery, emergency surgery, or are acute infections.

Design outcomes

Primary

MeasureTime frame
postoperative delirium ;

Secondary

MeasureTime frame
Glutathione antiperoxidase;Severity of postoperative delirium;IL-6;CRP;

Countries

China

Contacts

Public ContactPing Li

The First Affiliated Hospital of Chongqing Medical University

8191170@qq.com+86 130 6233 7738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026